SDC1 and neuroendocrine neoplasm: This result contrasts with the results shown by Shimada et al. 2013 [49], who reported that SDC1 contributes to tumor progression by stabilizing cancer-initiating cells, favoring the growth and incidence of metastases in the TRAMP mouse, which is also characterized by the presence of neuroendocrine tumors [49].